radiation-sensitizing agents

Preferred Label : radiation-sensitizing agents;

MeSH definition : Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.;

MeSH synonym : radiation sensitizing drugs; radiosensitizing agents; drugs, radiation-sensitizing; sensitizing agents, radiation; agents, radiosensitizing; radiation-sensitizing drugs; agents, radiation sensitizing; radiation sensitizers; sensitizers, radiation; radiosensitizing drugs; drugs, radiosensitizing; agents, radiation-sensitizing; radiation sensitizing agents; Radiation Sensitizer; Sensitizer, Radiation; Radiosensitizing Agent; Agent, Radiosensitizing;

Related MeSH term : Radiation-Sensitizing effect; Effect, Radiation-Sensitizing; Radiation Sensitizing Effect; Radiosensitizing Effect; Effect, Radiosensitizing; Radiosensitizing Effects; Effects, Radiosensitizing; Radiation-Sensitizing Effects; Effects, Radiation-Sensitizing; Radiation Sensitizing Effects;

MeSH annotation : note entry term RADIATION-SENSITIZING EFFECT: use only for the radiation sensitizing effect of a chemical substance;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D011838;

UMLS CUI

C0034541;

ATC code(s)
- efaproxiral [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
Currated CISMeF NLP mapping
- Radiosensitizing Agent [NCIt concept]
Indexing information
- 2-(1-benzylindol-3-ylmethylene)-1-azabicyclo(2.2.2)octan-3-ol [MeSH Supplementary Concept]
- 4-(2-cyclohexylethoxy)aniline [MeSH Supplementary Concept]
- 4-(ethylsulfonyl)-1-iodo-2-nitrobenzene [MeSH Supplementary Concept]
- 9-methyl-2-(oxiran-2-ylmethoxy)-9H-carbazole [MeSH Supplementary Concept]
- N,N,N-tris(2-(2-nitro-1H-imidazol-1-yl)ethyl)amine [MeSH Supplementary Concept]
- PLA-695 [MeSH Supplementary Concept]
- T83 compound [MeSH Supplementary Concept]
- Vinorelbine [MeSH Descriptor]
- cixutumumab [MeSH Supplementary Concept]
- copper (II) 2,3,7,8,12,13,17,18-octabromo-5,10,15,20-tetrakis(3-(1,2-dicarba-closo-dodecaboranyl)methoxyphenyl)porphyrin [MeSH Supplementary Concept]
- monascuspiloin [MeSH Supplementary Concept]
Metaterm(s)
- oncology [CISMeF Metaterm]
Record concept(s)
- Radiation-Sensitizing agents [MeSH concept]
- Radiation-Sensitizing effect [MeSH concept]
See also
- radiation tolerance [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol [MeSH Supplementary Concept]
- 2,2,5,5-tetramethyl-1-pyrrolidinyloxy-3-carboxylic acid [MeSH Supplementary Concept]
- 2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide [MeSH Supplementary Concept]
- 3-aminobenzamide [MeSH Supplementary Concept]
- 4-boronophenylalanine [MeSH Supplementary Concept]
- 4-nitroacetophenone [MeSH Supplementary Concept]
- 5-thio-D-glucose [MeSH Supplementary Concept]
- AK 2123 [MeSH Supplementary Concept]
- C 1311 [MeSH Supplementary Concept]
- Dimethyl Fumarate [MeSH Descriptor]
- FTI 277 [MeSH Supplementary Concept]
- JNJ 26854165 [MeSH Supplementary Concept]
- N(1),N(14)-bis(ethyl)homospermine [MeSH Supplementary Concept]
- RB 6145 [MeSH Supplementary Concept]
- Tirapazamine [MeSH Descriptor]
- WR 77913 [MeSH Supplementary Concept]
- Wortmannin [MeSH Descriptor]
- aluminum tetrasulfophthalocyanine [MeSH Supplementary Concept]
- beta-lapachone [MeSH Supplementary Concept]
- bimolane [MeSH Supplementary Concept]
- bisbenzimide ethoxide trihydrochloride [MeSH Supplementary Concept]
- bromodeoxyuridine [MeSH Descriptor]
- buthionine sulfoximine [MeSH Descriptor]
- carbogen [MeSH Supplementary Concept]
- chloroaluminum phthalocyanine [MeSH Supplementary Concept]
- cisplatin [MeSH Descriptor]
- desmethylmisonidazole [MeSH Supplementary Concept]
- diamide [MeSH Descriptor]
- efaproxiral [MeSH Supplementary Concept]
- etanidazole [MeSH Descriptor]
- etofylline clofibrate [MeSH Supplementary Concept]
- fluoromisonidazole [MeSH Supplementary Concept]
- glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination [MeSH Supplementary Concept]
- hexaamminecobalt(II) [MeSH Supplementary Concept]
- hypericin [MeSH Supplementary Concept]
- irofulven [MeSH Supplementary Concept]
- lisofylline [MeSH Supplementary Concept]
- lonidamine [MeSH Supplementary Concept]
- methylformamide [MeSH Supplementary Concept]
- metronidazole [MeSH Descriptor]
- misonidazole [MeSH Descriptor]
- ninhydrin [MeSH Descriptor]
- ornidazole [MeSH Descriptor]
- perflubron [MeSH Supplementary Concept]
- pheophorbide a [MeSH Supplementary Concept]
- phthalocyanine [MeSH Supplementary Concept]
- phytochlorin [MeSH Supplementary Concept]
- pimonidazole [MeSH Supplementary Concept]
- sanyang xuedai [MeSH Supplementary Concept]
- stichoposide [MeSH Supplementary Concept]
- tetraphenylporphine sulfonate [MeSH Supplementary Concept]
- tezacitabine [MeSH Supplementary Concept]
- tretazicar [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Radiosensitizing Agent [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients